In addition, time‐course treatment of Huh7 and HepG2 cells with cycloheximide (CHX) showed degradation of β‐catenin with prolonged treatment time, and this degradation was attenuated after FGF9 overexpression in liver cancer cells (Figure 4D,E). This evidence concerns the gene FGF9 and liver cancer.